Curetis Archives

News and Trends 30 Jan 2020

Austrian Genomics Company Joins Fight Against Coronavirus

Ares Genetics will use next-generation sequencing technology from the Chinese genomics company BGI Group to track and control the spread of a new coronavirus originating in China. A new strain of coronavirus, dubbed 2019-nCoV and originating in the Chinese city of Wuhan, has caused widespread concern in recent weeks. While only 20% of people with […]

January 30, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 28 Oct 2019

AI-Driven Antibiotic Susceptibility Test Launched in Austria

Ares Genetics, an Austrian subsidiary of the German Curetis Group, has launched an early access program for its AI-driven antibiotic susceptibility test. The company, which focuses on molecular diagnostics, has a large, regularly updated database of genetic information on disease-causing microbes including strains showing antimicrobial resistance. The new test uses high-resolution sequencing to gain genetic […]

October 28, 2019 - 2 minutesmins - By Helen Albert

News and Trends 4 Sep 2019

US Genomics Firm Combines with Curetis to Tackle Antibiotic Resistance

The German biotech Curetis has been combined with the US genomics company OpGen to pool their molecular diagnostics expertise in the fight against antibiotic resistance. “After more than one year of intensive discussions and negotiations for many months, it feels great to be able to announce the transaction today,” Oliver Schacht, the CEO of Curetis, […]

September 4, 2019 - 3 minutesmins - By Jonathan Smith

antimicrobial resistance molecular diagnostics 1

Interview 3 Jul 2018

Fighting Antimicrobial Resistance with Fast Molecular Diagnostics

Antimicrobial resistance is predicted to kill more people than cancer by 2050. Is it possible to prevent it? At our Refresh Meetup in Berlin, I talked with Achim Plum, CBO of the diagnostics company Curetis, about what are our best bets to turn the tables in the fight against the threat of antimicrobial resistance. The […]

July 3, 2018 - 8 minutesmins - By Clara Rodríguez Fernández

News and Trends 4 Apr 2018

First Rapid Molecular Diagnostics Test for Lung Infections Approved in the US

Curetis is the first company to receive FDA approval to market a molecular diagnostic test for lung infections in the US. The test reduces the time taken to reach a diagnosis from several days under five hours. The FDA has given Curetis, a German biotech, the green light to launch its first-in-class Unyvero platform for diagnosing lung infections […]

April 4, 2018 - 3 minutesmins - By Alexander Burik

In Depth 9 May 2017

Rise of the Superbugs: How is Biotech Fighting Antibiotic Resistance?

Fewer antibiotics are produced as development costs rise. We reached out to a few companies addressing the serious issue of antibiotic resistance. Antibiotic resistance is one of the greatest threats to our societies and health systems, and the number of antibiotic-resistant bacteria is growing at a disquieting rate. The estimated number of people killed by […]

May 9, 2017 - 8 minutesmins - By External Contributor

News and Trends 6 Apr 2017

This New Biotech counts with the Largest Antibiotic Resistance Database

Curetis has launched Ares Genetics, a company that will use the biggest antibiotic resistance genetic database to advance the diagnose of infections. Ares Genetics, the new subsidiary of Curetis, will investigate the genetic foundation of antibiotic resistance to develop new approaches for the rapid diagnose of specific resistance in patients with infections, as well as tools to […]

April 6, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 15 Mar 2017

What are the Best Countries to Recruit Biotech Talents in 2017?

Before the “who to recruit” phase, an important question is “where?” We ran through the top countries in which to look for talent in biotech and had a look at what you can expect from each cluster. For each one of them, we also referenced some data on the biotech, life science and research ecosystems to […]

March 15, 2017 - 10 minutesmins - By External Contributor

News and Trends 13 Dec 2016

How Will Biotech Overcome the Huge Challenges of Microbial Resistance?

The emergence of multi-drug resistant pathogens is alarming the scientific community since their growth is increasing at an incredibly fast pace. We gathered a group of experts to discuss how biotech is addressing this pressing concern and what the next big thing will be in the field of antimicrobial resistance. Achim Plum, CCO of Curetis, highlighted that […]

December 13, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

Screenshot 2016 10 25 at 3.57.12 PM e1477403929643

News and Trends 25 Oct 2016

This Diagnostic Tool beats the Standard for Respiratory Infection Tests

Curetis is drastically reducing the time required to test for severe infectious diseases. The newest incorporation is expected early next year and could soon substitute the hospital standards. Curetis is a German biotech that commercializes diagnostic technologies for infectious diseases. After a very successful IPO last year, the company is advancing its Unyvero platform for fast diagnostics. The […]

October 25, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

curetis blood infection diagnostic pathogen resistance

News and Trends 20 Jun 2016

This Sepsis Detection Test saves 24h for Faster Treatment

Curetis has received great results for its diagnostic kit. This new technology to detect sepsis is delivering the same results as standard tests, but it’s faster by 24 hours – critical time to deal with life-threatening infections. Based in Stuttgart (Germany), Curetis was the only German biotech to do an IPO in 2015. It did so with a bang, […]

June 20, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 21 Mar 2016

This CEO was responsible for the Only German Biotech IPO in 2015…

Whilst at the Sachs conference last week, I had the chance to meet with Oliver Schacht, the CEO of Curetis. It’s the only German Biotech which went public last year and this was a good enough reason to have a chat (the company is also really interesting, obviously). Curetis is based in Stuttgart in the […]

March 21, 2016 - 1 minutemin - By Philip Hemme

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us